Positive Results for RejuvenAir® Metered Cryospray™ in COPD Patients with Chronic Bronchitis

RejuvenAir® feasibility study demonstrate strong safety profile and clinically meaningful improvement on Quality of Life measures at 6-month follow-up in Chronic Bronchitis patients.